Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

计划入组 45 人 · 首次发布于 2023 年 9 月 6 日

CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL)

计划入组 45 人 · 首次发布于 2023 年 5 月 12 日

Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

计划入组 633 人 · 首次发布于 2021 年 12 月 17 日

MALT-1 inhibitors (diffuse large B-cell lymphoma)

Tisagenlecleucel(Kymriah)

Rx

anti-CD19 CAR T-cell therapy (acute lymphoblastic leukemia/diffuse large B cell lymphoma)

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Belarus

B. Braun Ltd. Centre of Excellence Infection Control

CARGO Therapeutics

United States

EMA Grants Orphan Designations for Rare Disease Treatments in Pulmonary Fibrosis and B-Cell Lymphoma

Multi-Omics Study Reveals Proteogenomic Signature of High-Risk Diffuse Large B-Cell Lymphoma

FDA Expands Adcetris Approval for Relapsed Large B-Cell Lymphoma Treatment